Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance
Therapies acting on complex glial networks carry inherent risks, and amyloid-related imaging abnormalities (ARIAs) exemplify how biomarker-guided vigilance can prevent harm [507]
The link between GSTs and the MAP kinase pathway provides a rationale as to why in many cases the drugs used to select for resistance are neither subject to conjugation with GSH, nor substrates for GSTs
Not clinical evidence
HLO: Healthy 7.710 7 vs NASH 1.4510 8 , p0.05), and CD81 (PHH: Healthy 1.910 8 vs NASH 1.9510 8 , p0.05
US$ 22.27
US$ 27.32
US$ 24.13
US$ 21.60
US$ 26.89
